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Staphyloxanthin is a golden pigment that is produced by the bacterium, 
Staphylococcus aureus. This pigment is a virulence factor for the bacterium and is 
hypothesized to have the dual function of acting as an antioxidant to protect against action of 
oxidizing agents, a common form of immune response in the human body, and stabilizing the 
cell membrane, much like cholesterol does in human cells. In this experiment, mutants with 
little or no staphyloxanthin were successfully created using UV light. These mutants were 
then tested against various agents, including oxidants, cell membrane active antibiotics, and 
Pseudomonas aeruginosa exoproducts, to determine if there was a difference in bacterial 
response between the mutants and the wild type, or non-mutated, bacterium that still 
produced the staphyloxanthin pigment. I hypothesized that the lack of staphyloxanthin would 
cause the mutant bacteria to be more drastically affected by the antibacterial agents. This was 
tested using a standard Kirby-Bauer method where the test compounds are impregnated into 
standard filter paper discs and tested against lawns of bacteria. Zones of inhibition were 
measured after 48 hours. Among other data recorded was the influence on pigment 
production of the various test compounds. Results indicate that differentially pigmented 
mutants of S. aureus differ in their response to cell membrane active antibiotics and P. 
aeruginosa exoproducts. 
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Staphylococcus aureus is a gram-positive bacterium that is endemic, or native, to the 
human body. Despite its reputation as a common pathogen, most strains of S. aureus are not 
harmful when relegated to their normal habitat on the body (1). However, if the bacterium is 
able to enter the blood stream or an open wound, this can be one of the most problematic 
bacterial infections to overcome. Not only can Staph aureus directly infect humans, it also 
impacts human health and economics because of its infection of livestock and presence in the 
food industry. Much of the damage S. aureus causes is due to its virulence, adaptivity 
(including acquisition of antibiotic resistance), and interactions with other bacteria (2). 
S. aureus and Pseudomonas aeruginosa: 
 
S. aureus is present in many cases of superinfection in the human body. In a 
superinfection, two or more bacterial species inhabit the same wound or area and both 
contribute to the symptoms exhibited by the patient. These infections are extremely difficult 
to treat and can occur in a variety of places in the human body (3). One of the most common 
cohabitants in S. aureus superinfections is the bacterium, Pseudomonas aeruginosa. 
P. aeruginosa is an opportunistic pathogen that is not highly infectious by itself (3). 
However, when present in a polymicrobial community, such as in superinfections, both P. 
aeruginosa and S. aureus become more pathogenic than they are when isolated (3). Common 
examples of superinfections involving these bacteria are infections found in cystic fibrosis 
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(CF) patients, burn infections, and diabetic ulcers (3). When both of these bacteria are 
present, P. aeruginosa secretes a host of exoproducts that interfere with the growth, 
metabolism, and homeostasis of S. aureus, making it more susceptible to both antibiotic 
treatment and host immune defense (3). Two of these P. aeruginosa products, 4-hydroxy-2- 
heptylquinoline-N-oxide (HQNO) and pyocyanin, was focused on throughout this study. 
HQNO belongs to a class of molecules known as 2-alkyl-4-(1H)-quinolones (AQ) (4). 
This particular AQ is a cytochrome B inhibitor (4). In the S. aureus cell, cytochrome B acts 
in the cellular membrane to assemble the enzyme, nitrate reductase (5,6). This enzyme allows 
the bacteria to reduce nitrogen and use it as an electron donor (5,6). This means that the 
ability of S. aureus to use the electron transport chain (ETC) to generate ATP is severely 
inhibited when HQNO is present (3). This exoproduct is one of the main mechanisms for 
allowing P. aeruginosa to overtake S. aureus in superinfections. It is because of these 
properties of HQNO that it was chosen as one of the antibacterial agents in this study. 
Pyocyanin is a blue-green pigment that is one of the characteristic exoproducts 
secreted by P. aeruginosa. Like HQNO, pyocyanin also acts to inhibit the respiration of S. 
aureus, eliminating its ability to use the ETC for ATP production (7). This forces the S. 
aureus to adopt a phenotype known as a small-colony variant phenotype (SCV) (7). These 
SCV colonies are then susceptible to pyocyanin dependent reactive oxygen species (ROS) 
that are extremely bactericidal to the colonies in their weakened state (7). Secretion of 
pyocyanin is quorum-sensing-regulated, meaning that the bacteria have to reach a certain 
threshold of growth before this exoproduct is produced and secreted (7). In CF patients, this 
is one of the major problem-causing exoproducts, causing problems with cellular respiration, 
3  
ciliary function, and catalase inactivation (7). In experiments performed in a mouse model 
testing P. aeruginosa virulence, full bacterial virulence was not attained until pyocyanin 
biosynthesis had begun (7). This exoproduct was also used as an antibacterial agent in this 
study. 
Implications in Healthcare: 
 
In the field of healthcare, S. aureus is one of the major problems facing physicians 
and researchers around the world. Often synonymous with hospital acquired “staph” 
infections, S. aureus can cause many different types of infections in the human body. This 
bacterium is responsible for infections of orthopedic implants, bacterial septicemia, food 
poisoning, skin infections, cystic fibrosis superinfections, and many other kinds of infections. 
One of the most concerning attributes of S. aureus is its ability to adhere to artificial 
surfaces in the human body and form biofilms (8). A biofilm is essentially a “bacterial city” 
composed of multiple layers of bacteria that work in unison to secrete compounds that bind 
them together as a functional unit while simultaneously protecting the colonies against host 
immune defenses (8). From this “protective city,” the bacteria are essentially encased within 
a protective shell and thus, immune to most if not all outside attack. 
Biofilm formation occurs in three phases: attachment, accumulation, and dispersal 
(8). In the attachment phase, an initial cell, or group of cells, adheres to an artificial surface 
and begins to replicate. Once a threshold number of cells is reached, the accumulation phase 
begins and a signal protein is sent out that communicates to the cells in the S. aureus colony 
that they need to secrete a host of proteins to form the biofilm matrix. One of these proteins 
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is called polysaccharide intracellular adhesion protein, or PIA (8). This protein allows the 
cells to adhere together and form the biofilm (8). Other secreted proteins contribute to the 
adhesive abilities of the bacterial colony, as well as the near invulnerability that accompanies 
the formation of the biofilm (8). In the dispersal stage, cells fragment off of the biofilm and 
enter the bloodstream, thus causing secondary infections and biofilms to form in other areas 
of the body (8). 
Due to the near impervious nature of biofilms, while inside, S. aureus is able to 
continue to divide and spread via fragmentation without being threatened by any host 
immune defenses. This means that even the smallest biofilm can result in a large problem if 
left untreated. Infections such as this can occur on any artificial implantation in the human 
body, including total joint replacements (TJRs) such as knees, hips, and shoulders, heart 
valve replacements, and even electrical devices such as pacemakers (8). Because of the 
impervious nature of biofilms, the only way to treat infections such as these are replacement 
revision surgeries that involve completely removing the specific artificial surface involved in 
the infection and replacing it with a new unit. These infections often result in an increased 
risk of morbidity or mortality due to additional hospital time, additional time in surgery, and 
the potential for superinfection. This leads to large financial cost and the great potential for 
decline in patient health (8). 
Another potential complication of S. aureus is a condition known as bacterial 
septicemia. Simply described as “blood poisoning,” septicemia is a condition characterized 
by a multisystem, or body-wide, response to a bacterial infection (9). Response can be varied, 
but to be considered, “severe sepsis,” typical symptoms include an elevated white blood cell 
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count, tachycardia, and in the most severe cases where sepsis worsens to a condition known 
as “toxic shock,” multisystem organ dysfunction and hypotension, or low blood pressure (9). 
Organ dysfunction typically affects the brain, respiratory system, and cardiovascular system 
and can result in severe long-term decline in organ function or even death. A few of the most 
at-risk groups for septicemia are neonates, infants and the elderly. According to a study 
published in the Indian Journal of Medical Microbiology, neonatal septicemia accounts for 
around a quarter of all neonate deaths in the world and many of the septicemic infections are 
a result of S. aureus (10). 
Economically, S. aureus also has had a variety of impacts across the world in both the 
food service and hospital setting. In 2013 alone, antibiotic-resistant infections such as MRSA 
cost the United States 55 billion dollars in direct and indirect burden on the healthcare industry 
(11). One example of this is in the case of a total knee arthroscopy revision surgery (TKAR). 
The average cost of a TKAR is 68,624 dollars (12). This is 16,814 dollars more than the 
average initial TKA surgery (12). This number reflects the average cost paid by Medicare for 
each surgery in 2016 and will only continue to increase as the cost of healthcare rises. Expected 
to rise from 500,000 TKAs per year in 2005 to 3.48 million TKAs per year in the year 2030, 
if the trend of revisions required for these TKAs continues, the increased burden on the 
healthcare system will be astronomical (12). Popularity of these surgeries also continues to 
increase, despite economic cost. Between the years 2009-2010, in the face of a large, 
countrywide, economic recession, the yearly growth of TKAs increased from 6.1% per year to 
13.5% per year (12). A similar trend is being seen in other total joint arthroscopies such as 
shoulders and hips as well. 
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Another example of the economic burden created by MRSA infections is related to the 
increase in length of stay, or LOS, of the patient. A study performed in Switzerland in 2013 
demonstrated that MRSA infection results in a hospital stay that is 2.1-4.8 times longer than 
patients that did not have a MRSA infection (13). Patients incurred an extra cost of 800 Swiss 
Francs (roughly 850 U.S. dollars) per day (13). This resulted in an additional 6.5 million Swiss 
Francs (6.9 million U.S. dollars) in healthcare burden being placed on the Swiss economy (13). 
In the U.S., this problem is even more pronounced. The rate of MRSA infection in the U.S. 
inpatient setting is 46.3 per 1,000 individuals (14). Due to the difference in population between 
the U.S. and Switzerland, the economic burden placed on the U.S. economy is even greater 
than that placed on the Swiss economy. As LOS continues to rise in hospitals and HA-MRSA 
rates increase, the economic burden will continue to increase and be a drain on economies 
around the world. 
Implications in Athletics and the Community: 
 
S. aureus is also a major concern in the field of athletics, particularly team sports such 
as football, basketball, volleyball, and weight lifting where players are frequently in contact 
with one another, increasing the potential for spread of pathogenic strains of bacteria (15). 
Among these populations, S. aureus, or staph, infections are generally thought of as a skin 
infection characterized by large, pus filled, boils and skin lesions that are highly pathogenic 
and generally spread quickly throughout a team of athletes if not adequately addressed 
through environmental sterilization and antibiotic treatment (15). These lesions are often 
accompanied by cellulitis and pain, and are best treated by draining the boil and ingestion of 
a broad range antibiotic (15). However, in recent years, the effectiveness of this form of 
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treatment has seen a drastic decline due to the increased prevalence of strains of S. aureus 
that are resistant to methicillin-based oral antibiotics (15).  These strains have come about 
due to over-prescription by physicians and lack of adherence to the prescribed antibiotic 
regimen by patients (16). This typically occurs because a portion of the S. aureus population 
survives the initial round of antibiotic treatment and confers this increased resistance to the 
next generation of S. aureus colonies (16). Over multiple generations, entire strains of S. 
aureus have evolved a complete resistance to an antibiotic.  In the case of methicillin 
resistant S. aureus, or MRSA, many mutations have evolved to make the bacterial strains 
resistant to beta-lactam antibiotics such as penicillin and methicillin (12). A few of these 
mutations lead to a decreased penetration into the cell membrane, the alteration of enzyme 
active sites, or the degradation of the antibiotic by bacterial enzymes, namely beta-lactamase 
(16). MRSA infections are concerning to healthcare professionals because many of the 
antibiotics that were traditionally used to treat these infections are beta-lactams, making most 
of the common treatments for S. aureus infections ineffective. When dealing with MRSA, 
physicians have traditionally turned to stronger antibiotics, such as vancomycin, to treat these 
infections. However, in recent years, there has been an increase in S. aureus isolates that are 
even resistant to treatment by vancomycin (17). Dubbed vancomycin resistant S. aureus, or 
VRSA, these new isolates are thought to have emerged due to a combination of the heavy use 
of vancomycin to treat MRSA infections and the incredible ability of S. aureus to adapt 
quickly to new environmental stressors (17). Already incredibly infectious, certain strains of 
S. aureus also quickly adapt and become nearly impossible to treat, raising many concerns 
among the medical community. 
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Infections by S. aureus, have also become a problem on college campuses and in 
schools all over the world. Because S. aureus is endemic, or naturally found, on 
approximately a third of human beings and many of these strains are becoming methicillin 
resistant, it is not surprising that in a place such as a college campus where thousands of 
people come together every day, this bacterium would thrive. Typically dubbed community 
acquired MRSA infections, or CA-MRSA, these infections are distinguished from hospital 
acquired MRSA infections or HA-MRSA purely by the location in which the patient acquires 
the bacterium (18). Surprisingly, college campuses have been shown to closely mimic 
conditions found in hospitals due to the large population of people that are under immune 
depression due to factors such as stress, antibiotic use, autoimmune diseases, lack of sleep, 
and many other factors that play into the ability of the immune system to fight infectious 
diseases. CA-MRSA infections present in a variety of ways ranging from minor soft tissue 
infections to necrotizing pneumonia, a rare form of pneumonia where the infectious 
bacterium induces tissue death in the lungs. Although atypical, severe cases are becoming 
more common as the population of S. aureus bacteria continues to evolve increased virulence 
and infectious capabilities (18). 
Implications in Food Service: 
 
Although typically thought of in regard to healthcare and hospitals, S. aureus has a 
reach that extends past healthcare into fields such as food service. For example, a recent 
study in Brazil assessed the risk that S. aureus biofilm formation poses to fish production, 
one of the major food sources of the country (19). Fish are particularly susceptible to 
bacterial colonization from S. aureus due to the high nutrient content, relatively neutral pH, 
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and many other favorable environmental conditions of the tissue of the fish (19). This study 
looked at a few problems facing this part of the Brazilian food supply, and found that one of 
the main problems was the ability of S. aureus to adhere to the stainless-steel surfaces of the 
machinery used to process the fish and form biofilms, creating the same problem that occurs 
when biofilms form on artificial medical implants. This resulted in a constant source of 
contamination that could not be easily destroyed, even when sterilization methods such as 
heat, chemicals, and pressure were applied (19). S. aureus colonization in food supplies is 
one of the leading causes of food poisoning across the world. This is due to the ability of S. 
aureus to produce a host of toxins, appropriately dubbed staphylococcus enterotoxins, that 
when secreted from the S. aureus cells, induces the common symptoms of food poisoning 
(20). Roughly 50-70 percent of S. aureus strains are able to produce these enterotoxins and 
these strains account for around 8 percent of food poisoning cases reported in the European 
Union (20). These enterotoxins, particularly enterotoxin A, induce vomiting, headache, 
abdominal pain, and diarrhea, and have a particularly rapid onset, often occurring within 1-6 
hours of ingestion (20). Infections resulting in food poisoning have occurred frequently in 
European countries such as France where S. aureus is the second most implicated bacteria in 
food borne diseases, directly following Salmonella (20). This shows that S. aureus infection 
is a threat that affects all countries, both developed and undeveloped, without discrimination. 
Some of these enterotoxins, such as staphylococcus enterotoxin Q (SEQ), exhibit 
incredible resistance to heating and pepsin activity (21). This combination of traits means 
that, if present in food, even cooking cannot eliminate the risk of food poisoning. This toxin 
also has extreme emetic activity, meaning that it causes severe vomiting, and is not degraded 
10  
by peptides in the stomach. Therefore, the effects of this toxin are felt for much longer than 
many of the other, less stable, enterotoxins (21). Hence, SEQ is an extremely prevalent and 
present threat to the food service industry. In the case of SEQ, not even the correct method of 
cooking, cleaning, or food preparation would mitigate the risk of ingesting the active form of 
this toxin (21). Thankfully, only a few S. aureus strains currently have the ability to produce 
this toxin and therefore this is not an immediate threat to the food service industry. 
Recently, S. aureus infections have transcended humanity and crossed into livestock 
as well, resulting in livestock associated MRSA or LA-MRSA (22). This crossover threatens 
the health of humanity’s food supply resulting in many economic implications associated 
with this food source. This means that S. aureus plays an even larger role in economics 
worldwide than has been historically attributed to the bacterium (22). Directly related to this 
is the economic loss incurred by food service establishments when S. aureus infections 
occur. In 1984, a study published by Ewen C. Todd about the economic loss resulting from 
food poisoning outbreaks stated that costs incurred by a food service establishment in the 
case of a food poisoning outbreak ranged from 16,690 dollars to 1,000,000 dollars which, 
when the 136 percent inflation rate since 1984 is taken into account, amounts to about 39,375 
dollars to 2,359,192 dollars today (23). Cost incurred by a restaurant or business can be 
attributed mostly to loss of business and potential law suits (23). This steep amount, even on 
the low end, could bankrupt a small business and shows that, as a population, we need to 
combat the ability of these bacteria to resist our bactericidal treatments. 
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S. aureus virulence: 
 
S. aureus is able to be so diverse, adaptable, and destructive due to a variety of 
weapons, known as virulence factors that this bacterium possesses. These factors include 
Staphylococcus enterotoxin, catalase, peroxidase, beta lactamase, hemolysins, and toxic 
shock syndrome toxin (11). The focus of this research will be upon a virulence factor, called 
staphyloxanthin, that provides S. aureus with its name. 
Staphyloxanthin is a pigment produced by S. aureus and is the reason this 
staphylococcal species is named aureus, or gold, in Latin. Like most carotenoid pigments, 
staphyloxanthin falls in the typical yellow/orange color range under most conditions (23). 
This pigment has two proposed functions in the S. aureus cell, the protection against 
oxidative stress and the stabilization of the bacterial cell membrane. The first function, 
protection against oxidative stress, allows the bacteria to persist longer in the host, even 
while under attack from host immune defenses (23). This is made possible because the 
pigment acts as an antioxidant, acting to protect the bacterial cell against host defenses such 
as neutrophils that mainly use free-radical oxidation to attack the S. aureus cells (23). This 
was demonstrated in an experiment that tested the number of S. aureus colonies that were 
able to grow in the presence of increasing concentrations of hydrogen peroxide (H2O2), one 
of the main reactive oxygen species (ROS) that are used by white blood cells in the oxidative 
attack of pathogens. The results showed that as the concentration of H2O2 increased, fewer S. 
aureus colonies were able to grow in comparison to the groups treated with lower amounts of 
H2O2. This led to the conclusion that staphyloxanthin acts as an antioxidizing agent in the 
bacterial cell (23). In this proposed pathway, staphyloxanthin acts to scavenge free radicals, 
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protecting the integrity of the bacterial cell from oxidation (23). The pigment presumably 
acts alongside other compounds such as catalase to neutralize ROS thereby allowing the cell 
to cope with oxidative stress (23). This is why H2O2 was chosen as one of the test reagents in 
the current study. Clorox bleach was also used as a reagent because the main ingredient, 
sodium hypochlorite, also acts as an oxidizing agent and has bactericidal properties. 
Membrane carotenoids such as staphyloxanthin have also been hypothesized to 
regulate the S. aureus cell membrane stability in much the same way that cholesterol does in 
the human cell membrane, effectively stabilizing and allowing for adaptability of the 
membrane based on environmental conditions (24). Alteration of cell membrane fluidity and 
permeability has been hypothesized to enable S. aureus cells to partially detoxify ROSs and 
allow the cell to better defend against attacks by human white blood cells (24). This 
characteristic of staphyloxanthin may also help protect the S. aureus colonies against attack 
by antibiotics such as daptomycin that act on the cell membrane level. Daptomycin was 
chosen as a test reagent for this study due to its method of attack on the bacterial cell 
membrane. Daptomycin affects seven critical cell membrane proteins that collectively act to 
regulate the cellular membrane potential in the S. aureus cell (25). By altering the membrane 
potential of the cell, the antibiotic causes cell death because the bacteria lose the ability to 
transport materials in and out of the cell. This means that they cannot transport ions across 
the membrane and thus cannot correctly manage its water content, leading to cell lysis or 
crenation, both of which result in death (25). Daptomycin also causes the conglomeration of 




The two hypothesized functions of staphyloxanthin, protection against oxidation and 
stabilization of the cell membrane, were tested throughout the course of this experiment 
using pigment mutants that produce less staphyloxanthin than the wild type strain of S. 
aureus used for experimentation. If staphyloxanthin protects S. aureus from host defenses 
and/or antibiotics because of its antioxidant and cholesterol-like cell membrane stabilization 
abilities, and we test the antibiotic resistance of mutants that produce differing amounts of 
staphyloxanthin, then I expect that pigment mutants that produce less staphyloxanthin will be 
more susceptible to both ROSs and antibiotics that attack at the cell membrane level because 
the mutants are not able to produce this pigment in the quantity that the wild type is. This 
will be measured in the form of zone of inhibition data from the Kirby-Bauer antimicrobial 
susceptibility test. In this test, a plate of Mueller-Hinton agar is inoculated with bacteria and 
then a filter disk, loaded with an antimicrobial agent, is placed on the plate. After 48 hours of 
incubation, a clearing around the disk where no bacterial colonies were able to grow is 
measured and used to determine the susceptibility of the bacteria to that particular 
antimicrobial agent. This test was also used to compare mutated and unmutated S. aureus 
strains obtained from the American Type Culture Collection (ATCC) to determine if any 
difference exists between the ROS and antibiotic resistance capabilities between the mutated 
and non-mutated forms of the S. aureus. 
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MATERIALS AND METHODS 
 
Selection of S. aureus Strain: 
 
The strain of S. aureus used for this study was chosen based upon the amount of 
staphyloxanthin pigment that the bacteria produce. ATCC strain 13565 is known for 
producing large amounts of staphyloxanthin pigment and thus is a model species for pigment 
study. 
Selection of Test Media: 
 
For this experiment, the ideal substrate was one that would allow for rapid growth of 
the S. aureus, allow for easy visibility of pigmentation, meaning the medium was a neutral 
color, and encourage the production of staphyloxanthin by the S. aureus colonies. Seven 
media were selected to test as potential candidates for use in this experiment. These were 
Mueller-Hinton agar (MHA) (Difco Laboratories, Detroit, Michigan), tryptic soy agar (TSA) 
(Neogen Laboratories, Lansing, Michigan), brain-heart infusion agar (BHI) (Neogen 
Laboratories, Lansing, Michigan), nutrient agar (NA) (Neogen Laboratories, Lansing, 
Michigan), starch agar, gelatin agar, and Staphylococcus 110 agar (S110) (Neogen 
Laboratories, Lansing, Michigan). Each medium was streaked in replicates of five with the S. 
aureus strain using a quadrant streak plate method and then incubated at 37 C for 48 hours 
(26). Growth and pigmentation were ranked on a scale of one to five, one being least amount 
of growth and least amount of staphyloxanthin produced, and five being the most for both 
categories. Each plate was scored and the scores of the five replicates of each type of 
medium were added up to determine the ideal medium for use in further experimentation. 
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Determination of Mutagenesis Parameters: 
 
The next step of experimentation was the mutation of the original strain of S. aureus 
(ATCC 13565) with the goal of obtaining pigment mutants that produced less 
staphyloxanthin than the wild-type (WT), or original, strain. This was done using the 
quadrant streak plate method (26) to inoculate S. aureus onto an MHA plate, then 
immediately exposing the plate to ultraviolet (UV) light at 254 nanometers, the optimal light 
range for bacterial mutagenesis, with the lid off (27). UV exposure was performed using a 
model SI-950 UVP incubator as the light source. The first phase of experimentation was 
determining the optimal distance from the UV light, located at the top of the incubator, and 
the optimal time of exposure that would result in plates that were densely colonized, but had 
colonies that were isolated enough to see a distinct pigment difference. It was also important 
that the colonies were isolated enough to be taken from the plate without risking 
contamination from other colonies. Initially, six inoculated plates were placed on the bottom 
shelf of the incubator, located 8 inches away from the UV light source, and exposed for times 
of 15, 30, 45, 60, 75, and 90 seconds. After exposure in the UV incubator, all six plates were 
incubated at 37 C for 48 hours. After incubation, plates were examined to determine if any of 
the treatments met the criteria outlined earlier. Next, the same process was done for the same 
time periods using the middle shelf, located 5.5 inches away from the UV light source. 
Finally, the process was repeated using the top shelf of the incubator, located 3 inches away 
from the UV light source. A set of six plates was inoculated using the quadrant streak plate 
method and exposed on the top shelf of the UV incubator for 2, 4, 6, 8, 10, and 12 seconds 
(26). 
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Mutagenesis and Mutant Phenotypic Isolation: 
 
The next step was to isolate colonies of S. aureus that exhibited decreased 
pigmentation after exposure to UV light. Eight plates, labeled A-H, were streaked using a 
quadrant streak plate method and exposed for seven seconds on the top shelf of the UV 
incubator. The plates were then incubated for 48 hours at 37 C. After incubation, the plates 
were examined and colonies that exhibited decreased pigmentation were selected and 
streaked onto fresh MHA plates that had been divided into four sections to optimize use of 
media. Eighteen possible pigment mutants were obtained (3 from plate A, 4 from plate B, 3 
from plate C, 3 from plate D, 4 from plate E, and 1 from plate G). Each potential pigment 
mutant was given its own section of an MHA plate. These plates were then incubated at 37 C 
for 48 hours to determine if the colonies were pigment mutants or just S. aureus colonies that 
had turned off their pigment temporarily, a trait that S. aureus is known for when it is not 
under environmental stress. The six mutants that retained their lack of pigmentation were 
then streaked onto separate MHA plates and incubated as above. This transfer method was 
performed a total of three times to ensure the new mutants retained their diminished 
pigmentation. 
Confirmation of Phenotypic Mutations: 
 
To determine that the newly isolated colonies were not contaminants (other bacterial 
species or other S. aureus strains), all presumed mutants underwent latex agglutination 
testing (Hardy Diagnostics, Santa Maria, California). Testing was performed using a sample 
of the wild type colony, designated WT, and each of the mutated bacterial strains (D1, D3, 
and E1) isolated in the previous experimental step. A Staph API test (bioMèrieux 
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Laboratories, St. Louis, Missouri) was also performed on the mutants and the WT by 
inoculating a series of 20 microtubes filled with various reactants used for the identification 
of different species of Staphylococcus and including different strains within these species. 
The entire panel was incubated for 24 hours at 37 C. After incubation, each test was assigned 
a numerical value based on whether the test was positive or negative and this number was 
used to identify the species of bacteria based on the manufacturer’s data base. If the 
experimental group of colonies matched the numerical code of the WT sample, it was then 
assumed that it was the same strain of S. aureus. 
Kirby-Bauer Antibiotic Susceptibility Testing: 
 
Reagents used in this portion of experimentation were 3% hydrogen peroxide, Clorox 
brand bleach, pyocyanin (Sigma Laboratories, Mumbai, India), daptomycin (Sigma 
Laboratories, Mumbai, India) HQNO (Enzo Laboratories, Farmingdale, New York), and 
blank discs (Hardy Laboratories, Santa Maria, California). 
The purpose of this phase of experimentation was to test if differential antibiotic 
resistance exists between the 4 samples using the Kirby-Bauer method to test antibiotic 
susceptibility of each strain. The method utilizes paper discs that were impregnated with the 
test chemical. Also known as the single-disk diffusion method, the Kirby-Bauer method 
involved inoculating a 0.85% saline solution with a bacterial isolate until it matched with a 
turbidity standard (McFarland 0.5 turbidity standard) (Sigma Laboratories, Mumbai, India) 
(28). After the saline suspension was created, a cotton swab was dipped into the saline 
solution for 3 seconds and then rolled along the inside of the test tube to eliminate excess 
moisture. The swab was then streaked across a standardized MHA plate containing 25 mL of 
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agar. The plate was then rotated 90 degrees and streaked again and rotated & streaked once 
more to ensure that the entire plate was coated in bacteria as an even inoculum. After 
inoculation, blank Hardy discs were placed equidistant apart on the MHA plate (28). For 
each trial per strain, 2 plates were used. One plate contained the discs inoculated with full 
strength 3% H2O2 (H) and Clorox bleach (C). The other plate contained the HQNO (HQ), 
Pyocyanin (P), and Daptomycin (D) discs. Once the discs were placed, the discs were loaded 
with the various antibacterial agents using a micropipette. Four microliters of antibacterial 
were loaded onto the H, C, and P discs. 2 microliters of HQ were loaded onto a disc and 20 
microliters of D were loaded onto a disc. Once all discs were loaded, the MHA plate was 
incubated at 37 C for 48 hours (1). This constituted one data point for one strain. This was 
repeated 30 times for each strain. 
After incubation, the diameter of each zone of inhibition was measured in mm at the 
widest part of the zone. Areas where enhanced pigmentation in the borders of the zones of 
inhibition were obviously exhibited were also noted. The results were then tabulated in 
Microsoft Excel for further analysis. 
Statistical Analysis: 
 
All statistical analysis was performed using R version 3.3.1. Data from Microsoft 
Excel was imported into R for analysis. Means and standard error for each treatment per 
strain were calculated and used to make a scatterplot with standard error bars. Quantile- 
quantile plots were then performed on each strain for each treatment to assess the normality 
of the data. A Fligner-Killeen test was then run on the data to determine homoscedasticity of 
the data set. Next, the Akaike’s An Information Criterion, or AIC, was used to determine 
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which model best represents the data. After choosing the simplest model, a one-way analysis 
of means (ANOMA) was performed to determine if a significant amount of difference 
existed between the means of the groups. If a statistically significant difference (p<0.05) was 
detected, then Welch’s two-way t-test was used as a post-hoc test to correct for 





Selection of Media: 
 
Mueller-Hinton agar was chosen as the medium for the remainder of the experiment. Not 
only did bacteria inoculated on this medium show the most volume of growth and amount of 
pigmentation produced, it is also the standard medium used for Kirby-Bauer antibiotic 
susceptibility testing (28) (Table 1). 
TABLE 1. Ranking of various media based upon volume of growth and amount of pigment 
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Determination of Mutagenesis Parameters: 
 
In the initial trial, six plates were inoculated, incubated on the bottom shelf of the 
incubator, and exposed to 254 nm UV light for 15, 30, 45, 60, 75, and 90 seconds. All of 
these plates exhibited growth, but the growth was far too dense to isolate individual mutated 
colonies. Next, the same process was done for the same time parameters on the middle shelf 
of the incubator and although less dense, the growth was still slightly too dense and was not 
exhibiting any difference in pigmentation that signaled mutagenesis in the bacterial cell. 
Finally, the same process was repeated on the top shelf of the incubator for 2, 4, 6, 8, 10, and 
12 seconds. The results showed that UV exposure for less than 6 seconds did not show 
sufficient bactericidal properties and resulted in growth too dense to isolate individual 
colonies that exhibited mutagenesis. Conversely, above the 8 second exposure mark, the UV 
was far too bactericidal and there were not enough colonies on the plate to acquire mutants 
with any significant frequency. However, between 6 and 8 seconds of exposure, colonies 
were sufficiently dense on the plate, able to be easily isolated, and showed differentiation in 






FIG. 1. MHA Plates exposed to 254 nm UV light on the top shelf (3 inches away from 




Mutagenesis and Mutant Phenotype Isolation: 
 
Eighteen possible phenotype mutants were isolated from the eight plates that were 
exposed to UV light for seven seconds on the top shelf of the UVP SI-950 UV incubator. Of 
these eighteen potential mutants, only six mutants retained their differential pigmentation 
through the initial transfer and incubation cycle. After the following three transfers 
performed on the remaining six mutants, only three of the six maintained their differential 
pigmentation. These were the E1, D3, and D1 mutant strains. The D3 strain exhibited a 
complete lack of staphyloxanthin production through these transfers and the E1 and D1 





FIG. 2. Four mutants that retained differential pigmentation after 3 transfers streaked on 
MHA. The WT strain, lower right quadrant, is the most heavily pigmented, E1 and D1,lower 
left and upper left quadrant, respectively, show decreased pigmentation, and D3, upper right 




Confirmation of Phenotypic Mutations: 
 
All four experimental groups tested positive in the latex agglutination test (Fig. 3). This 





FIG. 3. Latex agglutination test performed on each of the experimental groups. S. aureus is 
able to cause latex to clump, and thus gives the characteristic appearance seen above in all 
four tests 
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From the API 20S panel, all four groups yielded the profile number 6736150, which 
according to the manufacturer’s data base profile key, matches with S. aureus (Fig. 4). 
Because all of the groups yielded the same profile number, it can also be presumed that all 
four are the same strain of S. aureus. Due to these results, it is feasible and likely that the 





FIG. 4. API 20S test results of the three mutants and the WT strain of the bacterium. The 
WT was used as the positive control in this experiment as it was the original strain in the 
experiment. 
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Kirby-Bauer Antibiotic Susceptibility Testing 
 
The Kirby-Bauer Antibiotic Susceptibility testing method was used to determine 
whether the different mutants of S. aureus exhibited differential resistance to the antibiotics 
used (Fig. 5). One difference that was noted between the pigmented and non-pigmented 
strains was the increase in pigment production around the edge of the zones of inhibition in 
the H treatment (Fig. 5). This was only seen in the pigmented strains, E1 and WT, and not in 




FIG. 5. Left: Kirby-Bauer Susceptibility Test run on Mueller-Hinton Agar. Zones of 
inhibition are measured at the widest point of the zone of clearing in mm. In the plate on the 
left, increased pigmentation can also be noted around the edge of the zone. 
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Thirty iterations of the Kirby-Bauer method were performed in most treatments, the 
only exception being the D treatment where only 13 iterations were performed due to lack of 
antibiotic (Table 2). Means were calculated from the data gathered from the Kirby-Bauer 
testing and analyzed using a variety of statistical methods described below (Table 2). 
TABLE 2. Mean zone of inhibition size and number of measurements of Kirby-Bauer testing. 
Groups are divided by treatment and strain 
 
Treatment Strain # Measurements Mean Zone Diameter 
C WT 30 21.2 
D WT 13 15.7692308 
H WT 30 30.7666667 
HQ WT 30 0 
P WT 30 25.2666667 
C D3 30 22.5666667 
D D3 13 22.5384615 
H D3 30 30.0333333 
HQ D3 30 23.2666667 
P D3 30 32 
C E1 30 22.0333333 
D E1 13 19 
H E1 30 32.2333333 
HQ E1 30 0.7333333 
P E1 30 25.4666667 
C D1 30 21.8333333 
D D1 13 21.2307692 
H D1 30 26.2666667 
HQ D1 31 11.2903226 
P D1 30 29.8333333 
 
 




The Fligner-Killeen test for homoscedasticity of the data indicated that the data were 
not homoscedastic (χ2=67.933 df=17 p<0.001). Quantile-quantile plots determined that the 
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data were mostly normal with a few small violations to the normality. The AIC function 
determined that the most simple and appropriate model to assess the data was to analyze 
measurements given strain or treatment in the form of a one-way analysis of means 
(ANOMA). ANOMA analysis determined that no difference existed in the mean 
measurements of the zones of inhibition (ZOI) in the H (p=0.05972) and C (p=0.05037) 
treatments (Fig. 6). Differences were found to exist in the D (p=3.096e-07), P (p=9.379e-16), 
and HQ (p=8.749e-06) treatments (Fig. 6). In the groups where differences were exhibited, 
Welch’s two-way t-tests with a Holm adjustment were used as a post hoc test to determine 
where the differences existed within the treatment. Among the D treatment, the WT group 
varied from the E1 (padj=0.00886800), D1 (padj=0.00010808), and D3 (padj=0.00001236) 
groups (Fig. 6). The E1 group varied from both the D1 (padj=0.00609000) and D3 
(padj=0.00004991) groups and the D1 group varied from the D3 (padj=0.02916000) group 
(Fig. 6). In the HQ treatment, no inhibition was shown by the treatment in the E1 and WT 
groups, therefore for analysis purposes, these sets were excluded from the data analysis for 
this portion. Both the D1 and D3 zones were inhibited by the HQ treatment, indicating that a 
difference existed between these two groups and the two groups that were not inhibited (Fig. 
6). Statistical difference was also seen in the means between the D1 and D3 (padj<0.0001) 
groups (Fig. 6). In the P treatment, the WT group mean did not vary from the E1 




FIG. 6. Scatterplot depicting the means of each strain separated by which antibacterial agent 
they were treated with. Measurement on the Y-axis is in mm. Differences can be clearly seen 
in the HQ and P treatments between the E1 and WT groups and the D1 and D3 groups. Slight 
differences in the D and H treatments may also be noted 





S. aureus was shown to grow best on the Mueller-Hinton agar (MHA). The bacteria 
showed denser growth and a higher rate of pigment production on this agar medium 
compared to others tested. MHA is a general-purpose medium that is used for growing many 
different types of bacteria. It is also the standard agar used for the Kirby-Bauer antimicrobial 
susceptibility testing method (29). Because it yielded better results and could be continuously 
used throughout experimentation, it was chosen as the test medium for this study. 
Ultraviolet (UV) light has been shown as a consistent progenitor of mutagenesis 
pathways in bacteria (30). This has been demonstrated in a wide variety of bacteria spanning 
multiple taxa (30). One of the initial bacterial species where this method of mutagenesis was 
performed was E. coli (30). In E. coli, mutagenesis can be attributed to two distinct effects of 
the radiation, the blocking of DNA synthesis, which initiates both RNA and protein synthesis 
systems in order to repair the functionality of the DNA synthesis system, and photochemical 
modifications that result in mutation as subsequent DNA begins to repair (30). This results in 
DNA that is “semiconservative” or mostly the same as it was prior to exposure, but also 
carries distinct and quantifiable differences to the unexposed DNA (30). One hypothesis for 
explaining the bacterial response to UV light is known as the “SOS” hypothesis (31). This 
hypothesis proposes that UV mutagenesis is dependent upon the product of a multitude of 
genes, one of which is the recA+gene (31). This gene is only activated in times of UV 
exposure when the E. coli cell is experiencing extreme stress (31). When active, the recA+ 
gene is responsible for postreplication repair of E. coli DNA strands and is known for being 
error prone, thereby causing mutations in the genome of the bacteria (31).  Studies have 
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shown that S. aureus is similarly affected by UV exposure (32). S. aureus has been shown to 
be equally susceptible to both the bactericidal and photobiological effects of UV light, even 
exhibiting many of the same mutagenesis pathways seen in E. coli (32). It has also been 
demonstrated that quantifiable physiological mutations can be induced in S. aureus cells by 
exposure to UV light (33). One example of this was in an experiment performed by Swarupa 
et. al. In this experiment, the overexpression of the product of the gene streptomycin 3’’- 
adenylyltransferase 1, was induced by exposure to UV light (33). This led us to question 
whether or not differential pigment production could be induced in the same fashion. To 
accomplish this, exposure to UV light at 254 nm for 6-8 seconds at a distance of 3 inches 
from the light source was determined to be the optimum distance and time of exposure for 
mutagenesis while still supporting enough bacterial colonies on the plate to increase the 
chance that mutants would be seen in high enough frequency to be detected and isolated. 
After exposure to the UV light and subsequent incubation and growth, eighteen possible 
mutants were isolated from eight plates. They were each taken and restreaked onto another 
MHA plate and incubated. This process was repeated 3 times because S. aureus has the 
ability to increase and decrease its pigmentation in response to environmental factors. This 
was demonstrated in our experimentation around the edge of the zones of inhibition in the 
H2O2 treatment. Restreaks were necessary to ensure that what we were seeing weremutants 
that were not able to produce as much staphyloxanthin pigment rather than non-mutated 
bacteria that are producing less staphyloxanthin. After 3 rounds of re-culturing, only 3 
potential pigment mutants remained that had maintained their differential pigment 
production. 
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The next step in the determination of mutagenesis was to ensure that these potential 
pigment mutants were not just contaminants on the plate. This was performed in two steps. 
The first was to confirm that the isolates were S. aureus and the second was to ensure that if 
we did have S. aureus, they were all the same strain of S. aureus that differed only in the 
amount of pigment produced. The first determination was done using a latex agglutination 
test. The latex agglutination test is one of the standard methods for identifying S. aureus in 
the laboratory setting (34,35). These tests are commonly used to quickly identify S. aureus 
by binding to surface antigens and cellular exoproducts unique to the cell of S. aureus and 
not other Staphylococcus species (34,36). A few of these unique properties include the 
enzyme, coagulase, which is one of the main factors that causes the clumping of latex in this 
test, and the presence of a cell wall containing protein A (36). This test has been shown to 
have a 96-98% sensitivity and specificity to the S. aureus, meaning the prevalence of both 
false negatives and false positives resides in the 2-3% range, making it a useful assay for the 
discrimination between S. aureus and other bacterial species (35). In this test, particles in the 
solutions used precipitate with antigens located on the surface of the bacteria or exoproducts 
secreted by the bacteria (35). This causes a clumping to be seen almost immediately and in 
the case of our potential mutants, all tested positive and thus were determined to be S. 
aureus. 
The second determination, that all the S. aureus were the same strain, was necessary 
because S. aureus is endemic to the human body in 30-40% of the population and could 
therefore have been a contaminant from a human host (37). This was done using an API 20 
staph panel. In this panel, the mutants were tested against 20 different compounds designed 
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to test properties of different staphylococcal species for the purpose of differentiating 
between and identifying species and strains within the species Staphylococcus (38). This 
process is known as biotyping and has been shown to be extremely effective in identifying 
species of staphylococci (38). When using this test to identify bacterial species, an index is 
used in which multiple different species numbers are assigned to one species because many 
biological variants within each species is common, for this particular API panel, there are 
several hundred possible biotypes for S. aureus. This is why for the purposes of this 
experiment, this test was used to determine identity between strains. The likelihood that a 
contaminant wild-type strain of S. aureus from a human host or the environment exactly 
matches the experimental strain of S. aureus is extremely low, leading to the assumption that 
we were still dealing with mutants of the experimental strain rather than environmental 
strains that were non-pigmented. Based upon these results from the latex agglutination and 
API tests, we assumed that for the purposes of this study, the only difference between the 
groups was the differential production of the pigment, staphyloxanthin. It should be noted 
that there was no DNA analysis run on these groups to determine the exact mutations that 
had occurred as a result of the exposure to UV light. Ideally, whole genome sequencing 
(WGS) would be run on these mutants to determine if any other mutations are present that 
may be causing a differential response to anti-microbial treatment (39). However, that 
exceeded the scope and budget of this experiment. Although WGS has significantly dropped 
in price and increased in specificity in recent years, it still costs around 75-150 dollars per 
identification to obtain raw data, not even including the cost required for analyzing and 
representing these data (39). It is unlikely that the only mutations that occurred were in the 
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pigment production pathway. However, due to the similarity in the colony morphology and 
the fact that they all originated from the same strain and exhibited the same API results, the 
study continued under the assumption that the only important variable that would be taken 
into account was the differential pigment production. 
Staphyloxanthin carotogenesis is controlled, in part by the genes crtM and crtN, 
which encode two of the major aspects of the staphyloxanthin pathway, dehydrosqualene 
synthase and dehydrosynthase desaturase, respectively (40). It has been shown that 
eliminating the function of the crtM gene completely inhibits the ability of the S. aureus 
colony to produce staphyloxanthin (40). These genetic knockouts were shown to be much 
more susceptible to killing by hydrogen peroxide than the fully pigmented colonies with the 
intact crtM gene (40). This experiment led our laboratory to question two things, one whether 
we could generate pigment mutants using only UV light and two, whether or not this 
differential response would be seen in a similar fashion in treatments by other antimicrobial 
agents that attack aspects of the bacteria that staphyloxanthin directly influences. As shown 
by Liu et. al. in 2005, staphyloxanthin acts to help protect the S. aureus cell from oxidation 
by ROS such as hydrogen peroxide. However, it also acts to stabilize the cellular membrane 
by regulating the fluidity of the cellular membrane (25). 
In the Kirby-Bauer susceptibility testing performed in the present study, one of the 
interesting things that was noted was the increase in pigment production around the edge of 
the zones of inhibition by the E1 and WT groups in the H2O2 treatment. This is a 
phenomenon that has been documented a few times in our laboratory when staphyloxanthin- 
producing S. aureus is placed in close proximity to P. aeruginosa. This makes sense as P. 
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aeruginosa has been documented to increase or even induce pigmentation in S. aureus 
colonies, and this leads us to believe that S. aureus may be using a similar pathway to protect 
against oxidation in the H2O2 treatment. However, the phenomenon had not been previously 
seen in interactions between H2O2 and S. aureus. This may point to the abilityof 
staphyloxanthin to act as an antioxidizing agent that lends some extra protection to the 
bacterial colony when under oxidative stress. This effect of staphyloxanthin has been noted 
by prior research sources and has been proposed as one of the major functions of the pigment 
(23). Staphyloxanthin has been shown to scavenge free radicals and allow the bacterial 
colonies that produce it to have a marginally higher degree of oxidative protection than 
colonies that are not able to produce the pigment (9). In this experiment, however, no 
statistical difference was seen between the zones of inhibition of the different strains for the 
H2O2 or Clorox treatments. The combination of the increased pigmentation around the zones 
and the mean zone sizes may support the idea that although the staphyloxanthin acts as an 
antioxidant, it is not strong enough to make a statistical amount of difference. The 
staphyloxanthin in the Clorox and the H2O2 treatments, did not affect the resistance exhibited 
by any of the groups. It was noted in prior research that staphyloxanthin most likely did not 
play as large of a role in protection against oxidation as other factors such as catalase and 
superoxide dismutase (SOD), however how small of a role it plays was not discussed (23). 
Also seen in the Kirby-Bauer testing were differences between the groups in response 
to Daptomycin treatment. Daptomycin is a lipopeptide antibacterial that exhibits rapid 
activity against a wide range of gram-positive cocci (41). The mechanism of action of this 
antibacterial is to bind to the cell membrane and affect seven key transmembrane proteins 
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that regulate the osmotic potential of the bacterial cell membrane (41). This causes a 
disruption in DNA, RNA, and protein synthesis and quickly thereafter, cellular death (41). 
Daptomycin is an important antimicrobial that is used in treating both methicillin and 
vancomycin resistant S. aureus infections and has been shown to be extremely effective 
when typical beta-lactam antibiotics prove to be ineffective (41,42). To date, no mechanisms 
of resistance to daptomycin have been demonstrated by S. aureus, leading to the increased 
use of this antibacterial in high doses to treat difficult S. aureus infections (43). Results 
obtained from this study showed that the group that was able to produce the most pigment, 
the non-mutated WT group, exhibited the most resistance to the treatment, followed by the 
other pigmented group, E1, and then the two non-pigmented groups, D1 and D3. This 
matches the hypothesis that the presence of staphyloxanthin in the cellular membrane of S. 
aureus protects it, to an extent that is measurable, from attack by cell membrane active 
antimicrobials such as daptomycin. This could become particularly important in combination 
treatments that involve both anti-virulence and anti-microbial compounds. Anti-virulence 
therapies are defined as treatments that seek to alter the bacteria physiologically without 
killing it in a way that makes the bacteria more susceptible to host immune defense or 
traditional antimicrobial therapy (44). 
Another result seen in the Kirby-Bauer testing was in the P. aeruginosa exoproduct 
treatments. In the pigmented groups, E1 and WT, there was absolutely no susceptibility to 
the HQNO (HQ) treatment. However, in the non-pigmented groups, D1 and D3, clear zones 
of inhibition could be seen, some as large as 25 mm in the D3 group. This is particularly 
interesting because HQNO acts on the electron transport chain, particularly on the enzyme 
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nitrate reductase (5,45). Nitrate reductase facilitates the electron transfer from lactate to 
nitrate, an intermediate step in the bacterial electron transport chain (5,45). HQNO has been 
shown to have a strongly inhibitory effect on transfer of electrons (5,45). This may be related 
in some way to staphyloxanthin because nitrate reductase, like staphyloxanthin, is found in 
the bacterial cellular membrane, indicating that staphyloxanthin may be exhibiting a form of 
shielding or protective effect for the nitrate reductase, partially protecting it from HQNO 
attack, in the pigmented colonies (5,45). Staphyloxanthin had not been previously 
hypothesized to have any part in preserving the integrity of the electron transport chain; 
however, this association makes some sense as the electron transport chain is located in the 
cellular membrane of bacteria, not specific organelles like in eukaryotic organisms (5,45). 
The stark difference between the pigmented and non-pigmented groups, however, indicate 
that staphyloxanthin may have more of a purpose in protecting components important in 
electron transport and respiration rather than in protecting against oxidation. In the pyocyanin 
treatment, the same phenomenon was seen, just to a different degree. Pyocyanin also acts on 
the electron transport and respiration mechanisms of S. aureus, however the mechanism of 
action is different. Pyocyanin is a pigmented quorum-sensing-regulated exoproduct of P. 
aeruginosa. This exoproduct is one of the main virulence factors of P. aeruginosa and has 
been shown to have cytotoxic effects on both human epithelial cells and bacterial cells alike 
(7). Pyocyanin has been shown to be toxic to both respiring and non-respiring S. aureus cells 
(7). In non-respiring cells, pyocyanin acts as a ROS, oxidizing the bacterial cell (7). 
However, in respiring cells, this pigment acts to trigger the shift to a small colony variant 
(SCV) phenotype (7). These SCV colonies are less pigmented than their normal counterparts 
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and exhibit a non-functional electron transport mechanism (45). Although less efficient, this 
SCV phenotype has been demonstrated to be more hardy than the normal variant and is one 
of the main reasons that S. aureus is able to survive so long in the presence of P. aeruginosa 
in chronic infections such as cystic fibrosis (45). This phenotypic variant has been isolated in 
roughly 24% of patients with chronic cystic fibrosis infections and is significantly more 
resistant to antibacterial attack than the non-SCV phenotype (7). The mean zone of inhibition 
size for the pigmented groups was around 25 mm and for the non-pigmented groups was 
nearly 30 mm and 32 mm in the D1 and D3 zones, respectively, indicating that the 
staphyloxanthin pigment in the membrane had some sort of shielding effect against the 
mechanism of action unique to pyocyanin. 
The results seen in the treatments using the P. aeruginosa exoproducts begin to make 
sense when the frequency with which these two bacteria coinhabit the same space is taken 
into account. P. aeruginosa and S. aureus coinhabit a variety of infections such as cystic 
fibrosis, burn wounds, diabetic ulcers, and deep cuts. It is logical that as these two bacterial 
species have inhabited the same niches, they have also each evolved a variety of ways to win 
the ecological battle when they do come into contact. This also explains why coinfections 
involving these two bacteria, especially in the case of cystic fibrosis, can be continuous for 
10-20 years. Each of these bacteria are able to suppress and keep in check the growth of the 
other. In the case of P. aeruginosa, it secretes a whole host of compounds that are 
specifically targeted towards S. aureus (4). These compounds have no other purpose to the P. 
aeruginosa cell than winning the battle against S. aureus and often lend it the competitive 
edge against S. aureus, especially in chronic infections, such as cystic fibrosis. In cystic 
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fibrosis, the initial bacterial infection is often caused by S. aureus, however over the duration 
of the infection, P. aeruginosa usually coinhabits and is the pathogen that ends up killing the 
patient. In S. aureus, it has also been shown that in certain circumstances, P. aeruginosa 
induces the overexpression of staphyloxanthin pigment by S. aureus (44). This is made 
possible by the secretion of compounds by P. aeruginosa that induce upregulation of the 
genetic pathways that coordinate with carotogenesis (44). Also a result of these same 
molecules is the upregulation of the production of the enzyme, catalase, that helps protect S. 
aureus cell from oxidation by ROS (44). Interestingly enough, when P. aeruginosa is present 
in small quantities, as is common in the early stages of many of these coinfection 
circumstances, P. aeruginosa induces a higher degree of pathogenicity in the S. aureus cell, 
helping the bacteria to survive longer rather than being suppressed as is seen later in the 
course of the infection (44). As the infection progresses, P. aeruginosa becomes more 
prevalent and the concentration of exoproducts in the infection space increases, resulting in 
the inhibition of S. aureus. Competition between these bacteria, and others in the case of 
polymicrobial infections, often results in the increased pathogenicity of multiple bacteria and 
thus the increase in the severity of the infection (44). Polymicrobial infections are becoming 
extremely prevalent as these bacteria become more resistant to antimicrobials and continue to 
induce increased virulence in each other (44). 
Moving forward, various conclusions can be drawn from this study. One of the major 
conclusions is the need for increased research into anti-virulence therapies. One proposed 
method of this phenomenon is through the knockout of the gene Cold shock protein A 
(CspA) (45). CspA is a cold shock protein found in S. aureus that is tied to the Sig-B 
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mechanism that is required for maximum pigment production (45). In cells where this protein 
has been genetically knocked out, the bacteria are unable to produce any staphyloxanthin 
pigment (45). In this example, the lack of the ability to produce staphyloxanthin would result 
in an increased susceptibility to certain antimicrobials such as daptomycin. Another major 
advancement in this field was the discovery of the antibiofilm, antipathogenic, and 
anticarotenogenic properties of the chemical L-ascorbyl 2,6-dipalmitate (ADP). This is 
important to a variety of fields for multiple reasons, one of the major ones being the 
antibiofilm properties. Biofilm formation by S. aureus causes many problems in both the 
medical and food service industries (16). By inhibiting the ability of S. aureus to form 
biofilms, billions of dollars could be saved just in the reduction of revision surgeries alone 
(16). In the food service industry, a treatment such as this could be equally as helpful. In the 
example used earlier, Brazil’s fish production industry, where S. aureus biofilms that could 
not be destroyed were constantly forming and causing problems by contaminating the food 
source, a treatment that inhibits the bacteria’s ability to adhere to a surface would result in 
less money being spent on cleaning equipment and purchasing new machines to combat the 
biofilm formation (15). This would be beneficial to not only the producer, but also to the 
consumer, resulting in less food-borne illnesses and potentially eliminating one of the major 
causes of food poisoning worldwide. These therapies are promising in the face of the 
increased resistance to antimicrobials that bacteria such as S. aureus have been exhibiting in 
recent years. Because these new anti-virulence treatments do not affect the ability of bacteria 
to grow and reproduce, they also do not induce rapid evolutionary responses toward 
increased pathogenicity as is seen currently with antimicrobial treatments (46). Anti- 
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virulence treatments have the added benefit of not harming the endogenous flora already 
present on the human body (47). This means the chance that opportunistic pathogens will be 
able to cause infections by filling the ecological gap created by the loss of normal flora is 
much less likely than with traditional antimicrobial treatment (47). This would result in 
bacterial virulence being naturally inhibited by other bacteria and a sort of “crowd control” 
phenomena being seen, keeping pathogenic bacteria in check more naturally and through 
better means than bacteriocide (47). 
Anti-virulence treatment with ADP also has the potential to be extremely important 
due to its anticarotenogenic property. By definition, an anticarotenogenic compound would 
suppress S. aureus ability to produce the pigment staphyloxanthin, which has been shown to 
be a significant factor in S. aureus ability to resist antimicrobial attack. This was 
demonstrated in the P. aeruginosa exoproduct (HQNO and Pyocyanin) and Daptomycin 
treatments of the Kirby-Bauer susceptibility testing. By knocking out the staphyloxanthin 
production, we make the bacteria much more susceptible to routine antimicrobial treatment 
and host clearing (47). This phenomenon has also been demonstrated from other sources. In 
an experiment by Song et al., one of the introductory steps in staphyloxanthin biosynthesis 
was inhibited by using a product that is produced by a wide variety of microorganisms (48). 
The introduction of this compound to the S. aureus cell resulted in bacterial colonies that 
were unable to produce pigmentation and thus were rendered more susceptible to other 
treatments, such as hydrogen peroxide (48). Experiments such as this and many others show 
the potential promise that lies in the use of anti-virulence treatments as a way to combat not 
only S. aureus infections, but also the antimicrobial resistance epidemic as a whole. 
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The results of this study supported my hypothesis that the removal of staphyloxanthin 
from the bacterial cell resulted in a higher degree of antimicrobial susceptibility in most 
cases. The data indicated three major points about staphyloxanthin. The first point is that 
staphyloxanthin did not function to protect the bacteria from oxidation via H2O2  or Clorox to 
a statistically significant degree. This was indicated by the Kirby-Bauer antimicrobial 
susceptibility testing. The presence of H2O2 however, did increase the pigment production 
seen around the edge of the zones of inhibition in the pigmented groups, indicating that 
staphyloxanthin does probably play a minute role in antioxidation. The second point is that 
staphyloxanthin does act to protect the bacterial cell from antimicrobials that affect the 
cellular membrane. This confirms that staphyloxanthin is important in the protection of the 
bacterial cell against cellular membrane attack via antimicrobials altering the fluidity of the 
bacterial cellular membrane and that this quality of the pigment is protective in function. The 
final point is that staphyloxanthin protects against electron transport altering treatments, 
suggesting a role in maintaining the integrity of the electron transport chain in S. aureus. This 
role of staphyloxanthin had not been previously demonstrated and requires more research to 
determine by what exact method this occurs in the S. aureus cell. 
S. aureus is one of the most concerning pathogens facing our world today. It is a 
problem not only to the field of medicine, but also to the fields of food service, community 
health, sports, and even economics. This bacterium has a variety of factors that serve to 
increase its virulence, such as the pigment staphyloxanthin, allowing the bacterium to be 
dangerous in a variety of ways that are unique to this pathogen. Staphyloxanthin serves a 
variety of roles in the S. aureus cell that have been shown to include an extremely minute 
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amount of protection against oxidation and also significant protection of the bacterial cell 
membrane and electron transport chain. These functions have been shown to significantly 
increase the amount of resistance that the bacterium displays against a variety of 
antimicrobial agents and demonstrates that continued research into therapies that are able to 
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